Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

One year of oral calcium supplementation maintains cortical bone density in young adult female distance runners.

Winters-Stone KM, Snow CM.

Int J Sport Nutr Exerc Metab. 2004 Feb;14(1):7-17.

PMID:
15129926
2.

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.

Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S.

N Engl J Med. 1990 Sep 27;323(13):878-83.

3.

Effect of training mode and calcium intake on bone mineral density in female master cyclist, runners, and non-athletes.

Beshgetoor D, Nichols JF, Rego I.

Int J Sport Nutr Exerc Metab. 2000 Sep;10(3):290-301.

PMID:
10997953
6.

Oligo-amenorrheic long-distance runners may lose more bone in spine than in femur.

Gremion G, Rizzoli R, Slosman D, Theintz G, Bonjour JP.

Med Sci Sports Exerc. 2001 Jan;33(1):15-21.

PMID:
11194101
7.

The effects of a high calcium dairy food on bone health in pre-pubertal children in New Zealand.

Gibbons MJ, Gilchrist NL, Frampton C, Maguire P, Reilly PH, March RL, Wall CR.

Asia Pac J Clin Nutr. 2004;13(4):341-7.

8.

Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.

Bonnick S, Broy S, Kaiser F, Teutsch C, Rosenberg E, DeLucca P, Melton M.

Curr Med Res Opin. 2007 Jun;23(6):1341-9.

PMID:
17594775
9.

Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.

Clin Ther. 2007 Sep;29(9):1937-49.

PMID:
18035193
10.

Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.

Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, Bianchi G.

Nephrol Dial Transplant. 2009 May;24(5):1472-7. doi: 10.1093/ndt/gfn690. Epub 2008 Dec 15.

PMID:
19075192
11.
12.

Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.

Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.

J Am Geriatr Soc. 2007 May;55(5):752-7.

PMID:
17493196
13.

A follow-up study on the effects of a milk supplement on bone mineral density of postmenopausal Chinese women in Malaysia.

Ting GP, Tan SY, Chan SP, Karuthan C, Zaitun Y, Suriah AR, Chee WS.

J Nutr Health Aging. 2007 Jan-Feb;11(1):69-73.

PMID:
17315084
14.

Associations of genetic lactase non-persistence and sex with bone loss in young adulthood.

Laaksonen MM, Impivaara O, Sievänen H, Viikari JS, Lehtimäki TJ, Lamberg-Allardt CJ, Kärkkäinen MU, Välimäki M, Heikkinen J, Kröger LM, Kröger HP, Jurvelin JS, Kähönen MA, Raitakari OT; Cardiovascular Risk in Young Finns Study Group.

Bone. 2009 May;44(5):1003-9. doi: 10.1016/j.bone.2008.12.019. Epub 2009 Jan 3.

PMID:
19168163
15.

Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.

Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ.

J Rheumatol. 2009 Aug;36(8):1705-14. doi: 10.3899/jrheum.081207. Epub 2009 Jun 1.

PMID:
19487264
16.
17.

Site-specific response of bone to exercise in premenopausal women.

Winters-Stone KM, Snow CM.

Bone. 2006 Dec;39(6):1203-9. Epub 2006 Jul 28.

PMID:
16876495
19.

The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.

Colpan L, Gur A, Cevik R, Nas K, Sarac AJ.

Maturitas. 2005 Jul 16;51(3):246-53.

PMID:
15978968

Supplemental Content

Support Center